This application claims the benefit of U.S. Provisional Application Serial No. 60/157,696, filed Oct. 4, 1999, the contents of which are herein incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
4650674 | Aggarwal et al. | Mar 1987 | A |
4812557 | Yasushi et al. | Mar 1989 | A |
4883661 | Daly et al. | Nov 1989 | A |
4894226 | Aldwin et al. | Jan 1990 | A |
4931543 | Halenbeck et al. | Jun 1990 | A |
5034225 | Bennett et al. | Jul 1991 | A |
5078997 | Hora et al. | Jan 1992 | A |
5272135 | Takruri | Dec 1993 | A |
5340574 | Maneglier et al. | Aug 1994 | A |
5358708 | Patel | Oct 1994 | A |
5744132 | Warne et al. | Apr 1998 | A |
5795779 | McCormick et al. | Aug 1998 | A |
Number | Date | Country |
---|---|---|
0 229 016 | Jul 1987 | EP |
0 303 746 | Feb 1989 | EP |
921124 | Oct 1992 | IE |
WO9640784 | Dec 1996 | WO |
WO9951272 | Oct 1999 | WO |
Entry |
---|
Allen et al. Int J Pharm 1999 , vol. 187, pp. 259-272. Hybrid (BDBB) interferon-alpha.: preformulation studies.* |
Taneja et al. Biochem J. 1994, vo. 303, pp. 147-153. Increased thermal stability of proteins in the presence of amiino acids.* |
Heller et al. Biotechnol prog. 1997, vol. 13, pp. 590-596. Manipulation of lypphilization-induced phase seperation: Implications for pharmceutical proteins.* |
Wang et al. (1988 Supp.) “Parenteral Formulations of Proteins and Peptides: Stability and Stabilizers,” Journal of Parenteral Science and Technology 42:S1-S26. |
Chang et al. (1996) “Development of a Stable Freeze-dried Formulation of Recombinant Human Interleukin-1 Receptor Antagonist,” Pharmaceutical Research 13: 243-249. |
Chen et al. (1999) “Solubility of Recombinant Human Tissue Factor Pathway Inhibitor,” Journal of Pharmaceutical Sciences 88: 881-888. |
Number | Date | Country | |
---|---|---|---|
60/157696 | Oct 1999 | US |